No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Lonza Buys Vacaville (US) Biologics Site from Roche for $1.2 Billion to Increase Lonza’s Commercial Manufacturing Capabilities
On 20 March 2024, Lonza announced it has entered an agreement to acquire Genentech’s large-scale biologics manufacturing site in Vacaville, California (US) from Roche for US$1.2 Billion. The facility has a total capacity of around 330,000 liters which is reported to...